Follow us on Twitter

News

Endeavour Leadership Awards

Leah Wright and Chelsea Thorn from the Nanostructure and Drug Delivery Group (Prof Clive Prestidge), Centre for Cancer Diagnostics and Therapeutics, Cancer Research Institute, the have been successful in securing Endeavour Leadership Awards for 6 months and 12 months of overseas research, respectively. Leah will travel to Uppsala University in Sweden to work with Professor Christel Bergström utilising their state-of-the-art synthetic gastrointestinal permeability models to analyse protein and nanoparticle transport. Chelsea will travel to the Hemholtz Institute for Pharmaceutical Research Saarland in Germany to work with Professor Claus-Michael Lehr to learn highly sophisticated, bacteria-infected organoid models that will access the pre-clinical efficacy and tolerability of her bacterial-targeting formulations. Both PhD students are eagerly looking forward to the opportunity to experience research in different countries, all of which will uniquely benefit their PhD and future careers as scientists.

UniSA proudly delivering world class research with real impact

The 2018 Excellence in Research Australia (ERA) results assessed UniSA across 39 detailed fields of research and rated all at or above world standard.

Research Australia Highly Commended Award

Professor Bill Runciman, Australian Centre for Precision Health,  Cancer Research Institute, was recently invited to attend the Research Australia award night, where he received Highly Commended in the Health Services Research Award. The Award is for an individual who has provided leadership and made an outstanding contribution to health services research; has driven research that had led to a significant improvement in healthcare; and/or has championed the development of health services research field. View the video here.

Vice Chancellor and President’s Scholarships Success

Congratulations PhD candidate, Ramin Hassankhani Gharagozlou from the School of Pharmacy and Medical Sciences, (supervised by Professor Shudong Wang), who was successful in obtaining prestigious Vice Chancellor and President’s Scholarships recently. The $10,000 awards support recipients whose research project exemplifies the objectives of the Transformed PhD (tPhD) and who can demonstrate how they would use the scholarship to further these objectives.
The Vice Chancellor and President’s Scholarships will provide funding towards gaining engagement or experience with industry, overseas or domestic trips for the purpose of collecting data or input from an end user on the research project, travel to conferences to present a refereed conference paper, or other activities identified in the candidate’s application and approved by the selection panel.
Well done Ramin on your success!


Channel Seven Children’s Research Foundation funding

Cancer Research Institute researchers have been awarded funding through the Channel Seven Children’s Research Foundation for 2019:

  • Associate Professor Kristin Carson-Chahhoud: Mixed Reality and Holographic technologies (iHealth) to deliver cognitive and behavioural therapy for treatment of anxiety among teenagers with asthma
  • Dr Yu-Wen Su, Injury site-derived proteoglycan glypican-3 suppresses growth plate cartilage bony repair and bone fracture healing
  • Dr Mingfeng Yu, Developing a new therapeutic for childhood acute myeloid leukaemia (ECR)

New Director of the Cancer Research Institute, Professor Alan Boddy

25 February 2019

Alan Boddy Following the departure of Professor Ian Olver AM, we welcome Professor Alan Boddy who has recently commenced his new role as Director of the Cancer Research Institute.  Alan will also retain his duties as Head of School, Pharmacy and Medical Sciences

Farewell to the Cancer Research Institute's Inaugural Director, Professor Ian Olver AM

22 February 2019

Ian Olver

We bid a sad farewell to Ian Olver who made the decision to leave the CRI to pursue other ventures. Ian's contribution to the University as intially the Director of the Sansom Institute for Health Research, followed as the Inaugural Director of CRI has been invaluable. 

Ian Davey Research Thesis Prize 2019 - outstanding nominee

Congratulations goes to Dr Tahnee Dening from Pharmacy and Medical Sciences, and a member in the Centre for Cancer Diagnostics and Therapeutics, Cancer Research Institute,  whose thesis, entitled “Nanostructured clay materials for solidifying lipid-based drug delivery systems” was one of only four nominated for the 2019 Ian Davey Research Thesis Prize. Whilst not the overall winner, Tahnee’s thesis was recognised for its outstanding research and scholarly contribution. The Ian Davey Research Thesis Prize is awarded to the most outstanding research thesis leading to a Doctor of Philosophy in the preceding calendar year.

NHMRC Success: Funding announcement made

Researchers from the Cancer Research Institute have been awarded NHMRC Project Grant funding totalling $3million:

  • Prof Elina Hypponen: Identifying      pathways to dementia: a large-scale genetic study
  • Prof Alex Brown: Intervening      on social and health services practice to address social determinants of      Aboriginal social and emotional wellbeing: The Northern Pathways Project

The national outcomes are now available from the NHMRC website here.

Appointment to the 2019 ARC College of Experts

Professor Eva Bezak has been offered an appointment to the 2019 ARC College of Experts (College).  The College is made up of experts of international standing, drawn from all corners of the Australian research community, including from higher education institutions, industry and public sector research organisations. College of Experts members are engaged by the ARC for appointments of one to three years, during which time they play a key role in identifying research excellence, moderating external assessments, and make funding recommendations under the ARC’s National Competitive Grants Program.

Outcomes of the 2018 Research Theme Investment Scheme (RTIS)

Seed Funding is designed to support the formation or development of research that spans across traditional disciplinary boundaries, and that builds collaborative partnerships. This year 7 of the funded projects were from the Cancer Research Institute (in total 95 application across the University were made). The full listing of the successful Development Scheme and Seed Funding projects are available on the RIS website here.  

ARC Funding Success

Dr Sang Hong Lee in the Cancer Research Institute was awarded an ARC Discovery Project for the project titled Whole-genome multivariate reaction norm model for complex traits.

Let's map our DNA and save billions each year in health costs

10 January 2019
Dr Vijay Suppiah, a senior lecturer in pharmacy at UniSA and a member in the Australian Centre for Precision Health,  Cancer Research Institute, says PGx testing – mapping a person’s genetic makeup – is the most effective way to ensure patients are prescribed drugs which suit their specific DNA profile.

Adelaide's historic link to X-ray discovery comes full circle

18 December 2018
In 2021, the first proton therapy unit in the southern hemisphere will open in Adelaide. The treatment will revolutionise cancer therapy in Australia, says UniSA Professor of Medical Radiation, Eva Bezak.

Breast screening vastly reduces risk of cancer death 

3 December 2018
Women who undertake regular breast screening checks have a 60 percent lower risk of dying from breast cancer withoin 10 years of diagnosis, new research shows

'Strongest evidence yet' that being obese causes depression

November 2018
New research has found the strongest evidence yet that obesity causes depression, even in the absence of other heath problems.

Outstanding UniSA research recognised through new awards

November 2018
The incredible and innovative work of more than 70 of UniSA’s researchers has been recognised and celebrated through the first event of its kind to be held at the University.  UniSA has introduced a new suite of University-wide Research Awards, which were presented as part of the inaugural UniSA Research Day in late October.

UniSA helping to bring cheaper, needle-free vaccines to the world

13 November 2018
In an international collaboration between Sementis and Enesi Pharma, Sementis Ltd is partnering up with the experts in the field of Zika virus and chikungunya vaccine research at UniSA’s Experimental Therapeutics Laboratory at its Cancer Research Institute to evaluate a needle-free vaccination technology developed by Enesi Pharma for Sementis’ SCV-based vaccines. 

Fighting obesity - could it be as plain as dirt?  UniSA research digs up the fat-fighting power of clays.

31 August 2018
Investigating how clay materials can improve drug delivery, UniSA researcher and PhD candidate, Tahnee Dening serendipitously discovered that the clay materials she was using had a unique ability to “soak up” fat droplets in the gut.

Pain and cancer experts to tackle survivor pain

20 August 2018
A renowned pain scientist at the University of South Australia, Professor Lorimer Moseley, is teaming up with cancer expert Professor Ian Olver to fast-track a long-awaited intervention for cancer survivors struggling with persistent pain. 

UniSA wins funding for research into cancer, aging, alcohol abuse and 3D bioprinting for medical use

13 August 2018
The University of South Australia has been awarded more than $2.6 million in the latest round of Federal Government funding to further research into Australia’s most critical health issues. 

Almost half of UniSA’s funding announced today from the National Health and Medical Research Council (NHMRC) has been awarded to find potential treatments for cancer, specifically brain tumours, acute myeloid leukaemia, bone marrow and head and neck cancers. 

My cancer is in remission - does this mean I'm cured? - Professor Ian Olver AM, Director, UniSA Cancer Research Institute

June 2018
So you’ve been through cancer treatment and your doctor has called you in for “some good news”. Satisfied, she tells you your cancer is “in remission”.

What does this mean? Are you cured? Is the cancer gone forever? And what about all those stories you’ve heard of someone who thought they’d “won the battle” – but then their cancer came back?

Research Australia Health and Medical Research Awards 2018 - Nominees announced

Congratulations goes to Professor Bill Runciman (HLS) who has been successful in making it to the final two nominees of the Health Services Research Award Category. This Award is for an individual who has provided leadership and made an outstanding contribution to health services research, has driven research that has led to a significant improvement in healthcare and/or has championed the development of the health services research field. Bill’s nomination was successful due to his extensive work in developing patient safety and standards for the discipline of Anaesthesia.

SAHMRI Annual Scientific Meeting Research Showcase - Pitch Perfect Award

Associate Professor Kristin Carson-Chahhoud (HLS) was recently awarded the Pitch Perfect Award at the Annual Scientific Meeting which took place on 25-26 October. The Research showcase took place on day 2 of the meeting. Congratulations Kristin on winning the much anticipated 'Pitch Perfect' award.

CSL Florey Next Generation Nominees

Following a University-wide selection process, both CSL Florey Next Generation nominees were selected from our Division. The 2018 CSL Florey Next Generation Award will shortly be conferred to a PhD candidate who has demonstrated outstanding capability, creativity and potential in the biomedical sciences and/or health and medical research.

Our good wishes go to Alexandra Wade (PhD candidate in HLS) and Hayley Schultz (PhD candidate in PMB) who submitted applications and a short (90 second) video that answered the question “What research challenge do I intend to solve during the course of my career”.  Alex took a creative approach and her video can be viewed here, whilst Hayley chose a more conventional approach which can be viewed here, both are exceptional nominees!

Beat Cancer - Travel Grant Success

Congratulations goes to Naranie Shanmuganathan, (PMB PhD candidate) for her success in theBeat Cancer Project Travel Grant. The Beat Cancer Project is a South Australian state-wide initiative intended to support and advance cancer research within the state. It is funded by Cancer Council SA and the SA Government (through SA Health) and administered by the South Australian Health and Medical Research Institute (SAHMRI).  Naranie received $2500 in the conference attendance and travel subcategory, which she will use towards attendance at the America Society of Haematology conference.

Success in the Controlled Release Asia (CRA) Meeting

A large delegation from PMB attended the Controlled Release Asia (CRA) meeting in Singapore in September. Two PMB students Santhni Subramaniam (Honours) and Chelsea Thorne (PhD) were selected from a pool of 130 students and gave very impressive presentations; resulting in 1st and 3rd place respectively.  Congratulation on your terrific achievements; you can see Santhni’s particularly wide smile in receiving the 1st prize of registration for a future meeting in Valencia, Spain.

UniSA Ranks as Australia’s top university for income derived from industry partnerships

Congratulations to the enterprising spirit of UniSA’s dedicated and talented Health Science researchers and the team of people which support these partnerships to fruition. Their combined hard work has recently been reflected in the Times Higher Education 2018 rankings.

UniSA Professor Shudong Wang honoured at NHMRC awards

World renowned cancer researcher, UniSA Professor Shudong Wang, was honoured at the National Health and Medical Research Council's (NHMRC) annual Research Excellence Awards in Canberra on 27 June, winning the Top Development Grant for 2017.

UniSA’s $247m Cancer Research Institute opens - an epicentre for cancer and aligned research

The $247 million, 14-storey UniSA Cancer Research Institute will open its doors today adding research, development and teaching capacity to South Australia in its war against cancer and a range of other diseases.

UniSA and Qianhong-LeSun Pharma Group’s new Sino-Australian joint laboratory to fast track new cancer drugs

The University of South Australia and China's Qianhong-LeSun Pharma group have joined forces to establish a multi-million dollar Sino-Australian Joint Laboratory in Innovative Drug Discovery to fast track the development of new treatments for cancer.

Improving treatment outcomes of heads and neck cancers

The involvement of a Human Papilloma Virus (HPV) results in head and neck cancer (HNC) with specific biological characteristics. Observations show HPV positive cancers exhibit increased chemo and radiation sensitivity and a UniSA research team has received a generous donation to investigate how this connection can benefit patients.

Easing the painful experience of oesophageal cancers

Professor Sanjay Garg and his team in the Centre for Pharmaceutical Innovation and Development (CPID) are developing new drug delivery technologies to improve the quality of life of terminally ill oesophageal cancer patients.

Crowdfunding campaign – Reducing Pain for Cancer Survivors

Help us develop an online tool that incorporates the latest in pain science and cancer research to help cancer survivors manage persistent pain after treatment. Donate today.